만성 폐쇄성 폐질환의 동반상병분포와 사망에 영향을 미치는 요인

키워드

참고문헌 (45)

1. Vogelmeier CF, "Goals of COPD treatment : Focus on symptoms and exacerbations", Respir Med, 166, pp.105938~ (2020)[DOI]
2. Weir DL, "Non-adherence to COPD medications and its association with adverse events : A longitudinal population based cohort study of older adults", Ann Epidemiol, pp.S1047-2797(23)00228-4~ (2023)[DOI]
3. Agustí A, "COPD 2020 : Changes and challenges", Am J Physiol Lung Cell Mol Physiol, 319(5), pp.L879~L883 (2020)[DOI]
4. "Chronic obstructive pulmonary disease (COPD)"[URL]
5. Adeloye D, "Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease(COPD)in 2019 : A systematic review and modelling analysis", Lancet Respir Med, 10(5), pp.447~458 (2022)[DOI]
6. Almagro P, "Impact of comorbidities in COPD clinical control criteria. The CLAVE study", BMC Pulm Med, 24(1), pp.6~ (2024)[DOI]
7. Recio Iglesias J, "Management of the COPD Patient with Comorbidities : An Experts Recommendation Document", Int J Chron Obstruct Pulmon Dis, 15, pp.1015~1037 (2020)[DOI]
8. Divo MJ, "Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease", Respir Res, 23(1), pp.267~ (2022)[DOI]
9. Barnes PJ, "Senescence in COPD and its comorbidities", Annu Rev Physiol, 79, pp.517~539 (2017)[DOI]
10. Negewo NA, "COPD and its comorbidities : Impact, measurement and mechanisms", Respirology, 20(8), pp.1160~1171 (2015)[DOI]
11. Hillas G, "Managing comorbidities in COPD", Int J Chron Obstruct Pulmon Dis, 10, pp.95~109 (2015)[DOI]
12. Raherison C, "Comorbidities and COPD severity in a clinic-based cohort", BMC Pulm Med, 18(1), pp.117~ (2018)[DOI]
13. Divo M, "Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 186(2), pp.155~161 (2012)[DOI]
14. Hruschka H, "Comparing unsupervised probabilistic machine learning methods for market basket analysis", Rev Manag Sci, 15, pp.497~527 (2021)[DOI]
15. Ambika M, "Enhanced decision support system to predict and prevent hypertension using computational intelligence techniques", Soft Comput, 24, pp.13293~13304 (2020)[DOI]
16. Rao AB, "Application of market–basket analysis on healthcare", Int J Syst Assur Eng Manag, 14(Suppl 4), pp.924~929 (2023)[DOI]
17. Lee Y, "Patterns of multimorbidity in adults : An association rules analysis using the Korea Health Panel", Int J Environ Res Public Health, 17(8), pp.2618~ (2020)[DOI]
18. Ramasamy S, "Disease prediction in data mining using association rule mining and keyword based clustering algorithms", Int J Comput Appl, 42(1), pp.1~8 (2020)[DOI]
19. Ahmed I, "A deep-learning-based smart healthcare system for patient’s discomfort detection at the edge of internet of things", IEEE Internet Things J, 8(13), pp.10318~10326 (2021)[DOI]
20. Korean National Hospital Discharge In-depth Injury Survey guidebook, "Korea Disease Control and Prevention Agency", Korea Disease Control and Prevention Agency, ~ (2016)
21. Baek SU, "Estimated trends in hospitalizations due to occupational injuries in Korea based on the Korean National Hospital Discharge In-depth Injury Survey(2006-2019)", Epidemiol Health, 45, pp.e2023042~ (2023)[DOI]
22. Lee K, "The usefulness of present-on-admission data as an indicator of healthcare quality evaluation using the Korean National Hospital Discharge in-Depth Injury Survey data from 2006 to 2019", Risk Manag Healthc Policy, 16, pp.2309~2320 (2023)[DOI]
23. Lim H, "Analysis of treatment pattern in COPD patients using Health Insurance Claims Data : Focusing on inhaled medications", Korean J Clin Pharm, 32(3), pp.155~165 (2022)[DOI]
24. Ünvan YA, "Market basket analysis with association rules", Communications in Statistics-Theory and Methods, 50(7), pp.1615~1628 (2021)[DOI]
25. Sornalakshmi M, "RETRACTED ARTICLE : Hybrid method for mining rules based on enhanced Apriori algorithm with sequential minimal optimization in healthcare industry", Neural Comput Applic, 34, pp.10597~10610 (2022)[DOI]
26. Nicolaou M, "Association of a priori dietary patterns with depressive symptoms : A harmonised meta-analysis of observational studies", Psychol Med, 50(11), pp.1872~1883 (2020)[DOI]
27. Jhang KM, "Using the Apriori algorithm to classify the care needs of patients with different types of dementia", Patient Prefer Adherence, 13, pp.1899~1912 (2019)[DOI]
28. Zeng N, "Inferring implications in semantic maps via the Apriori algorithm", Lingua, 239, pp.102808~ (2020)[DOI]
29. Zeng S, "Automatically explaining machine learning predictions on severe chronic obstructive pulmonary disease exacerbations : Retrospective cohort study", JMIR Med Inform, 10(2), pp.e33043~ (2022)[DOI]
30. Skajaa N, "Comorbidities and mortality among patients with chronic obstructive pulmonary disease", BMJ Open Respir Res, 10(1), pp.e001798~ (2023)[DOI]
31. Lacedonia D, "Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients", Sci Rep, 11(1), pp.19251~ (2021)[DOI]
32. Luijckx E, "Joints effects of BMI and smoking on mortality of all-causes, CVD, and cancer", Cancer Causes Control, 30(5), pp.549~557 (2019)[DOI]
33. Perez TA, "Sex differences between women and men with COPD : A new analysis of the 3CIA study", Respir Med, 171, pp.106105~ (2020)[DOI]
34. Njoku CM, "Risk factors and associated outcomes of hospital readmission in COPD : A systematic review", Respir Med, 173, pp.105988~ (2020)[DOI]
35. Park SC, "Mortality of patients with chronic obstructive pulmonary disease : A nationwide populationbased cohort study", Korean J Intern Med, 34(6), pp.1272~1278 (2019)[DOI]
36. Lortet-Tieulent J, "International trends in COPD mortality, 1995-2017", Eur Respir J, 54(6), pp.1901791~ (2019)[DOI]
37. Jankowski M, "Epidemiological characteristics of 101, 471 patients hospitalized with chronic obstructive pulmonary disease(COPD)in Poland in 2019 : Multimorbidity, duration of hospitalization, in-hospital mortality", Adv Respir Med, 91(5), pp.368~382 (2023)[DOI]
38. Cheng Y, "Predictors for mortality in hospitalized patients with chronic obstructive pulmonary disease", Springerplus, 3, pp.359~ (2014)[DOI]
39. Song J, "Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19", Allergy, 76(2), pp.483~496 (2021)[DOI]
40. Dos Santos NCD, "Prevalence and impact of comorbidities in individuals with chronic obstructive pulmonary disease : A systematic review", Tuberc Respir Dis(Seoul), 85(3), pp.205~220 (2022)[DOI]
41. Eroglu SA, "Influence of comorbidities in long-term survival of chronic obstructive pulmonary disease patients", J Thorac Dis, 11(4), pp.1379~1386 (2019)[DOI]
42. Sawalha S, "The impact of comorbidities on mortality among men and women with COPD : Report from the OLIN COPD study", Ther Adv Respir Dis, 13, pp.1753466619860058~ (2019)[DOI]
43. Aramburu A, "COPD classification models and mortality prediction capacity", Int J Chron Obstruct Pulmon Dis, 14, pp.605~613 (2019)[DOI]
44. Aisanov Z, "Management of cardiovascular comorbidities in chronic obstructive pulmonary disease patients", J Thorac Dis, 12(5), pp.2791~2802 (2020)[DOI]
45. Hespanhol V, "Pneumonia mortality, comorbidities matter?", Pulmonology, 26(3), pp.123~129 (2020)[DOI]

관련 논문AI추천